Kezhen Li

机构：Guangdong Academy of Medical Sciences, Tongji Hospital, Huazhong University of Science and Technology · ORCID：0000-0001-7943-5389

发表论文 117 篇 · 总被引 3730 次 · h-index 31

代表论文

• Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial (2023 · The Lancet Oncology · 被引 84)
• Multiomic analysis of cervical squamous cell carcinoma identifies cellular ecosystems with biological and clinical relevance (2023 · Nature Genetics · 被引 79)
• Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response (2024 · Nature Genetics · 被引 27)
• The remodeling of ovarian function: targeted delivery strategies for mesenchymal stem cells and their derived extracellular vesicles (2024 · Stem Cell Research & Therapy · 被引 21)
• Mitochondrial damage causes inflammation via cGAS-STING signaling in ketamine-induced cystitis (2025 · Inflammation Research · 被引 16)
• Mitochondria in Mesenchymal Stem Cells: Key to Fate Determination and Therapeutic Potential (2024 · Stem Cell Reviews and Reports · 被引 16)